Hai Lun Jiang1,2,3, Qiang Zhang4, Yu Zheng Du1,3, Xiang Gang Meng1,3, Hai Peng Ban1,3, Yang Tao Lu5. 1. First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. 2. Tianjin University of Traditional Chinese Medicine. 3. National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin. 4. BeiJing Daxing District Hospital of Integrated Chinese and Western Medicine, Beijing. 5. Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Abstract
BACKGROUND: Many clinical trials and systematic reviews have suggested that acupuncture (include moxibustion) could be effective in the treatment of diabetic peripheral neuropathy (DPN). However, clinical practices vary greatly leads to different choices which are mainly based on personal experience. The aim of this Bayesian network meta-analysis is to compare the efficacy of different acupuncture methods for DPN. METHODS: Randomized controlled trials on acupuncture treatment of DPN published before January of 2021 will be searched in 9 databases including Medline, Web of Science, PubMed, Cochrane Library, Excerpta Medica Database, Sinomed, China National Knowledge Infrastructure, WanFang, and China Science and Technology Journal Database. The methodological assessment performed using the risk of bias assessment tool of Cochrane, and the level of evidence quality for the main results will be evaluated by a recommended grading, evaluation, formulation, and evaluation system approach. Bayesian network meta-analysis will be conducted using STATA V.14.0 and WinBUGS V.1.4.3. RESULTS: The primary outcome involves: clinical efficacy. The secondary outcomes include: motor nerve conduction velocity, sensory nerve conduction velocity, Toronto clinical scoring system, Michigan neuropathy screening instrument, the modified Toronto Clinical Neuropathy Scale, the Utah early neuropathy scale, or the neuropathy disability score, and adverse reactions. CONCLUSION: To find the most effective acupuncture therapy for the treatment of DPN supported by evidence-based medicine.
BACKGROUND: Many clinical trials and systematic reviews have suggested that acupuncture (include moxibustion) could be effective in the treatment of diabetic peripheral neuropathy (DPN). However, clinical practices vary greatly leads to different choices which are mainly based on personal experience. The aim of this Bayesian network meta-analysis is to compare the efficacy of different acupuncture methods for DPN. METHODS: Randomized controlled trials on acupuncture treatment of DPN published before January of 2021 will be searched in 9 databases including Medline, Web of Science, PubMed, Cochrane Library, Excerpta Medica Database, Sinomed, China National Knowledge Infrastructure, WanFang, and China Science and Technology Journal Database. The methodological assessment performed using the risk of bias assessment tool of Cochrane, and the level of evidence quality for the main results will be evaluated by a recommended grading, evaluation, formulation, and evaluation system approach. Bayesian network meta-analysis will be conducted using STATA V.14.0 and WinBUGS V.1.4.3. RESULTS: The primary outcome involves: clinical efficacy. The secondary outcomes include: motor nerve conduction velocity, sensory nerve conduction velocity, Toronto clinical scoring system, Michigan neuropathy screening instrument, the modified Toronto Clinical Neuropathy Scale, the Utah early neuropathy scale, or the neuropathy disability score, and adverse reactions. CONCLUSION: To find the most effective acupuncture therapy for the treatment of DPN supported by evidence-based medicine.
Authors: Maria T Chao; Dean Schillinger; Unity Nguyen; Trilce Santana; Rhianon Liu; Steve Gregorich; Frederick M Hecht Journal: Pain Med Date: 2019-11-01 Impact factor: 3.750
Authors: N H Cho; J E Shaw; S Karuranga; Y Huang; J D da Rocha Fernandes; A W Ohlrogge; B Malanda Journal: Diabetes Res Clin Pract Date: 2018-02-26 Impact factor: 5.602
Authors: Gesa Meyer-Hamme; Thomas Friedemann; Johannes Greten; Christian Gerloff; Sven Schroeder Journal: J Diabetes Date: 2020-12-02 Impact factor: 4.006
Authors: Mohammad Saud Khan; Fuyu Zou; Abdur Rahman Khan; Abdelmoniem Moustafa; Christopher H Schmid; Muhammad Baig; Omar N Hyder; Herbert D Aronow Journal: Am J Cardiol Date: 2020-05-16 Impact factor: 2.778
Authors: Larissa Shamseer; David Moher; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart Journal: BMJ Date: 2015-01-02
Authors: Gesa Meyer-Hamme; Thomas Friedemann; Henry Johannes Greten; Rosemarie Plaetke; Christian Gerloff; Sven Schroeder Journal: BMC Neurol Date: 2018-04-13 Impact factor: 2.474